Jung Pyo Lee studies various aspects of kidney health, particularly chronic kidney disease (CKD) and acute kidney injury (AKI). His research includes examining how blood proteins can help differentiate between types of kidney diseases, as well as how kidney function impacts overall health indicators like cholesterol levels. Lee also explores new treatment options for kidney fibrosis and strategies to predict and improve outcomes for patients undergoing kidney treatments. His research aims to improve the diagnosis and management of kidney-related conditions, which can have significant implications for many patients.
Key findings
In a study with 5,416 plasma proteins from 232 patients, machine learning achieved over 80% accuracy in identifying different types of primary glomerular diseases, aiding in non-invasive diagnosis.
Research showed that patients with higher alkaline phosphatase levels had a 47% greater risk of dying, and greater fluctuations in this enzyme indicated an 82% increased risk of mortality among CKD patients.
In an analysis of 157,000 individuals, poor kidney function was linked to harmful changes in fat levels, leading to lower good cholesterol (HDL) and increased triglycerides, heightening cardiovascular risk.
A new treatment using the drug 17-DMAG effectively reduced kidney fibrosis in lab tests, suggesting a potential new strategy to protect against kidney damage in CKD patients.
In a study involving nearly 3,000 adults, higher exposure to PFAS was associated with increased hypertension risk, highlighting the impact of environmental factors on kidney health.
Frequently asked questions
Does Dr. Lee study chronic kidney disease?
Yes, Dr. Lee focuses on chronic kidney disease and has conducted extensive research to understand its progression and treatment options.
What treatments has Dr. Lee researched?
Dr. Lee has researched treatments for kidney fibrosis using the drug 17-DMAG, and he has explored strategies to improve outcomes for patients with acute kidney injury.
Is Dr. Lee's work relevant to patients undergoing kidney transplants?
Yes, his research on predicting acute kidney transplant rejection through gut microbiome analysis is highly relevant for transplant patients.
What are the implications of Dr. Lee's research on heart health?
Dr. Lee's findings indicate that kidney function significantly affects cholesterol levels and overall heart health, which is crucial for patients with kidney disease.
How does Dr. Lee's work impact the management of hypertension?
His research highlights the connection between environmental factors like PFAS exposure and hypertension risk, providing insights into prevention strategies for people with kidney issues.
Publications in plain English
Study protocol for a consortium linking health medical records, biospecimens, and biosignals in Korean patients with acute kidney injury (LINKA cohort).
2026
Kidney research and clinical practice
Yun D, Han SS, Lee J, Kim Y, Kim K +15 more
Plain English This study looked at Korean patients with acute kidney injury (AKI) by examining their health records and samples to better understand how to treat them before their condition worsens. Researchers worked with around 1,500 patients who were receiving special kidney treatments and collected data over different time periods. They also developed an artificial intelligence model to help predict patient outcomes and create personalized treatment plans.
Who this helps: This research benefits patients with acute kidney injury and their doctors by improving treatment options.
Material-Level Integration of Magnetic Actuation and Triboelectric Sensing for Adaptive Soft Robotic Platforms.
2026
Advanced materials (Deerfield Beach, Fla.)
Kim J, Lee JP, Jang Y, Jeong JH, Baek YK +1 more
Plain English In this study, researchers developed a new material that combines magnetic actuation and sensing, making soft robots smarter and more adaptable. They achieved a remarkable 325% increase in voltage for sensing capabilities, while also enhancing the robot's ability to move and change shape using magnets. This is important because it allows for more compact and efficient robotic systems that can react to their environment in real time, eliminating the need for bulky extra parts.
Who this helps: This benefits patients and industries that use soft robots for tasks like rehabilitation or minimally invasive surgeries.
Mechanical Loading Alleviates BRONJ-Like Lesions Around Implants Under Osteoporotic Conditions: An In Vivo Experimental Model.
2026
Clinical oral implants research
Lee JP, Kuroshima S, Uto Y, Nakajima K, Sawase T
Plain English This study looked at how applying pressure to dental implants can improve the bone quality around them in rats that mimic osteoporotic conditions caused by bisphosphonate medication. The rats that received mechanical loading showed better bone health, with reduced areas of dead bone and more healthy bone cells compared to those that did not receive the loading. This is significant because it suggests that mechanical loading can help maintain healthier bone structures around implants in patients treated with similar medications, potentially preventing complications.
Who this helps: Patients with osteoporosis who need dental implants.
Chrysoeriol Exerts Antiplatelet Effects by Regulating cAMP/cGMP and PI3K/MAPK Pathway.
2026
Biomolecules & therapeutics
Lee GH, Lee JP, Wahab AA, Heo NY, Park CE +1 more
Plain English This study looked at chrysoeriol, a compound found in certain plants, to understand how it helps prevent blood platelets from sticking together, which can lead to heart problems. The researchers found that chrysoeriol successfully reduced platelet clumping caused by collagen, increasing levels of certain cellular molecules (cAMP and cGMP) and inhibiting key signaling pathways that promote platelet activation. These effects suggest that chrysoeriol could be an effective treatment to lower the risk of blood clots, which are serious in cardiovascular diseases.
Who this helps: Patients at risk of cardiovascular issues.
Machine learning survival analysis for predicting kidney disease progression in patients with acute kidney injury undergoing continuous kidney replacement therapy: An analysis of the LINKA database.
2026
Journal of critical care
Yun D, Hong A, Kim K, Lee J, Kim Y +16 more
Plain English This study looked at how to predict whether patients with acute kidney injury (AKI) would progress to end-stage kidney disease (ESKD) while they were receiving continuous kidney replacement therapy. Researchers analyzed data from 1,444 patients and created a machine learning model that could accurately identify those at risk for ESKD. The model, which focused on six important health factors, showed strong accuracy with a score of 0.811 for the test group. This is important because it helps doctors identify high-risk patients so they can receive better care and monitoring.
Who this helps: This helps doctors and healthcare providers who are treating patients with kidney issues.
Therapeutic reprogramming of circulating myeloid cells via signal regulatory protein α extracellular vesicles in acute kidney injury.
2026
Kidney international
Shin DU, Jo MK, Kwon M, Jeong Y, Cho B +10 more
Plain English This study looked at a serious condition called acute kidney injury (AKI), which can lead to long-term kidney problems and has a high risk of death. Researchers found that a protein called CD47 is increased in immune cells involved in kidney inflammation, and by engineering tiny particles from stem cells that can target and modify CD47, they were able to improve kidney function in mice. Specifically, a single treatment with these engineered particles led to better kidney health and less inflammation.
Who this helps: This helps patients with acute kidney injury and could benefit others facing similar inflammatory conditions.
Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment.
2026
Journal of the American Society of Nephrology : JASN
Lee SM, Lee MS, Jung HR, Lee J, Cho B +12 more
Plain English This study looked at a drug called 17-DMAG, which targets a protein named METTL3 to help treat kidney fibrosis, a condition that worsens kidney function in chronic kidney disease (CKD). The researchers found that 17-DMAG was effective in lowering METTL3 levels and reducing kidney damage in lab and mouse tests, demonstrating a significant decrease in collagen buildup and other signs of fibrosis. These findings are important because they suggest a new treatment approach that could protect against kidney damage and improve kidney health in patients with CKD.
Who this helps: Patients with chronic kidney disease.
YY1-Mediated Polycomb Group Function Safeguards Hematopoietic Stem Cells from Premature Aging.
2026
bioRxiv : the preprint server for biology
Saka S, Lee JP, Wang Y, Liu P, Liu Y +5 more
Plain English This study looked at how a protein called YY1 helps protect blood-forming stem cells from aging too quickly. Researchers found that when they removed the part of the YY1 protein responsible for its protective function, the stem cells started to act older; they produced more myeloid cells (a type of white blood cell) and lost their ability to keep regenerating over time. This is important because understanding how to prevent the aging of these stem cells could lead to better treatments for aging-related blood disorders.
Who this helps: This benefits patients with blood disorders, particularly older adults.
Commit to Quit: Essential Elements of a Novel Tobacco Intervention for Arab American Women.
2026
Health promotion practice
Lee JP, Inoue-Terris V, Salam L, Abdelhalim G, Mohrez H +1 more
Plain English This study looked into a program designed to help Arab American women in the San Francisco Bay Area quit smoking tobacco, particularly through waterpipes (shisha), and to educate them about the risks of tobacco use. The program included web meetings with experts and was shaped by input from community members, focusing on culturally relevant information about tobacco harms. The findings showed that this tailored approach was crucial for effectively supporting these women and could serve as a model for similar initiatives in other communities.
Who this helps: This helps Arab American women and their families by providing targeted support to reduce tobacco use and its related harms.
Functional and Morphological Outcomes of Duration-Dependent Electrical Stimulation in Silicone Conduit-Mediated Peripheral Nerve Repair in Rats.
2026
Bioengineering (Basel, Switzerland)
Su CF, Lu MH, Lee JP, Chen CC, Chen YH +1 more
Plain English This study investigated how electrical stimulation (ES) affects the healing of peripheral nerves in rats after a nerve injury. Researchers found that longer periods of stimulation (7 weeks instead of 3 weeks) led to better recovery, including faster nerve regeneration and improved movement abilities; specifically, the 7-week stimulation group showed significant increases in nerve conduction speed and muscle response measurements. This research is important because it reveals that sustained electrical stimulation can enhance nerve repair and recovery, potentially leading to better outcomes for patients with similar injuries.
Who this helps: This helps patients with peripheral nerve injuries.
Causal Effect of Kidney Function on Lipid Metabolism: An Integrated Population-Scale Observational Analysis and Mendelian Randomization Study.
2026
Kidney medicine
Kim M, Koh JH, Kim SG, Lee S, Kim Y +12 more
Plain English This study looked at how kidney function affects fat levels in the blood by analyzing data from over 157,000 people. Researchers found that lower kidney function led to harmful changes in fat profiles, such as lower good cholesterol (HDL) and higher unhealthy fats (triglycerides). This is important because it shows that people with weak kidneys may face a greater risk for heart disease due to these changes in fat levels.
Who this helps: This helps patients with kidney disease and their doctors by highlighting the need for regular monitoring of fat levels in their blood.
Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases.
2026
Journal of the American Society of Nephrology : JASN
Oh JI, Jeong K, Koh JH, Kwon JK, Cho S +12 more
Plain English This study looked at how blood proteins can help identify different types of kidney diseases, specifically primary glomerulonephritis (GN). Researchers analyzed 5,416 plasma proteins from 232 patients and found that a machine learning model could accurately distinguish between various GN subtypes, achieving over 80% accuracy for diseases like minimal change disease and IgA nephropathy. This is important because it offers a non-invasive way to diagnose kidney issues more effectively than current methods, potentially leading to better treatment options.
Who this helps: Patients with kidney diseases and their doctors.
Intra-individual fluctuations in alkaline phosphatase predict mortality and CKD progression: insights from a large CKD cohort.
2026
Clinical kidney journal
Kim Y, Wu PH, Kwon S, Han SH, Lee J +9 more
Plain English This study looked at how fluctuations in a blood enzyme called alkaline phosphatase (ALP) relate to the risk of death and severe kidney disease in patients with chronic kidney disease (CKD). Researchers found that patients with higher baseline ALP levels had a 47% greater risk of dying compared to those with lower levels. They also discovered that greater ALP fluctuations significantly increased the risk of death, with a variability measure indicating an 82% higher risk.
Who this helps: This information benefits patients with chronic kidney disease and their doctors by highlighting the importance of monitoring ALP levels for better health outcomes.
Rosuvastatin activates autophagyinhibition of the Akt/mTOR axis in vascular smooth muscle cells.
2025
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Lee S, Lee DH, Lee JP, Han JH
Plain English This study looked at how a medication called rosuvastatin affects the behavior of certain cells in blood vessels that contribute to heart diseases like atherosclerosis. Researchers found that rosuvastatin reduced the growth and movement of these cells by lowering key proteins involved in these processes and increasing a process called autophagy, which helps cells clean up damaged parts. This is important because it suggests that rosuvastatin could help prevent and treat vascular diseases by fine-tuning cellular responses that lead to unhealthy blood vessel changes.
Who this helps: This helps patients at risk for heart diseases, especially those with conditions like atherosclerosis.
Promoting Piezoelectricity in Amino Acids by Fluorination.
2025
Advanced materials (Deerfield Beach, Fla.)
Hu T, Lee JP, Huang P, Ong AJ, Yu J +5 more
Plain English Researchers focused on improving the electrical properties of certain amino acids, specifically by adding fluorine, which is a simple way to enhance their piezoelectric capabilities—meaning they can generate electricity when pressed or stretched. They found that the modified amino acid, called Cbz-Phe(4F), performs much better, producing a piezoelectric strength of about 17.9, compared to its unmodified counterparts, and can generate a voltage of about 2.4 volts when used in a device. This matters because it could lead to better sensors for sorting food and improving smart agricultural technologies.
Who this helps: This benefits farmers and food processors by providing more efficient and accurate quality sorting of agricultural products.
Plain English This study looked at how graphene quantum dots (GQDs) could help protect kidney cells from damage that leads to chronic kidney disease. The researchers found that in tests with animals, GQDs reduced inflammation and fibrosis, which are harmful changes in the kidney, by restoring healthy cell structures and lowering harmful calcium levels. This is important because it shows that GQDs might be a new way to prevent kidney damage and slow down disease progression.
Who this helps: This helps patients with kidney diseases and their doctors by providing a potential new treatment option.
Graphene Quantum Dots as Antifibrotic Therapy for Kidney Disease.
2025
ACS applied bio materials
Li L, Jin W, Kim J, Bae G, Yang SH +8 more
Plain English This study looked at how graphene quantum dots (GQDs) can help treat kidney disease, specifically a type known as renal fibrosis. Researchers found that GQDs reduced harmful oxidative stress and inflammation in kidney cells, and when tested on mice with kidney damage, they significantly lowered signs of fibrosis and cell death. These findings matter because they suggest a new potential treatment for chronic kidney disease, which affects millions and can lead to serious health issues.
Who this helps: Patients with chronic kidney disease.
A novel approach to the relation of multi-pollutant effect and kidney dysfunction: data analysis from the Korean National Environmental Health Survey Cycle 3 (2015-2017).
2025
Kidney research and clinical practice
Lee I, Noh J, Kim Y, An JN, Park JY +6 more
Plain English This study looked at how exposure to various environmental chemicals affects kidney health in a group of South Korean adults. Researchers found that a specific chemical, PCB153, was a major predictor of chronic kidney disease (CKD), particularly in middle-aged individuals. In fact, those with high levels of PCB153 had a 71.4% chance of developing CKD if they also had higher hemoglobin levels.
Who this helps: This research benefits patients at risk for kidney disease and healthcare providers looking to understand environmental influences on health.
Clinical implications of proximal tubular multicilia in glomerular diseases.
2025
Heliyon
Kim B, Weon B, Kim E, Park S, Jin W +6 more
Plain English This study examined the presence of multiciliated cells (MCCs) in the kidneys of 134 hospitalized patients to see if they relate to the severity of kidney diseases. It found that 68.3% of patients with glomerular diseases had these cells, with higher amounts observed in those with diabetic kidney disease (88.9%) or ANCA-associated glomerulonephritis (86.4%). Patients with more MCCs had a greater likelihood of developing end-stage kidney disease and a higher risk of death, making MCC levels a potential marker for predicting kidney health and outcomes.
Who this helps: This research can help doctors better assess kidney disease in patients.
Collaboration as a Catalyst for Change: Reducing Commercial Tobacco Use Among American Indian Youth Through Dedication to Community, Youth-Led Interventions, and Tradition.
2025
American Indian and Alaska native mental health research (Online)
Kornacki C, Rodriguez J, Rodriguez J, Hurtado A, Lee JP +11 more
Plain English This study looked at how a group of tobacco prevention programs in Southern California teamed up to reduce smoking among American Indian and Alaska Native youth, who have the highest rates of tobacco use in the U.S. By working together and organizing community events, including an annual youth summit, they involved young people and local elders, which led to increased participation and support from their communities. The collaboration has shown positive results, emphasizing how working together can help make a bigger impact on public health.
Who this helps: This helps American Indian and Alaska Native youth and their communities.
Serum fibulin-1 levels and target organ damage in patients at high cardiovascular risk: A prospective observational study.
2025
European journal of clinical investigation
Kim HL, Lee JP, Lee J
Plain English This study looked at a protein called fibulin-1 in the blood of 330 patients who are at high risk for heart problems. The researchers found that higher levels of fibulin-1 were linked to more severe damage to organs caused by cardiovascular disease; specifically, those with lower organ health had an average fibulin-1 level of 506 mcg/mL compared to 354 mcg/mL for those without damage. This matters because measuring fibulin-1 could help doctors assess the risk of serious heart issues in their patients.
Who this helps: Patients at high risk for cardiovascular disease.
Primary choledocholithiasis after cholecystectomy without hyperbilirubinaemia in a child with sickle cell disease.
2025
BMJ case reports
Thrower AI, Roberts A, Lee JP, Chumpitazi BP
Plain English The study looked at a unique case of a child with sickle cell disease who developed a condition called primary choledocholithiasis, which means stones formed in the main bile duct. This occurred despite the child not showing high levels of bilirubin, a substance often checked to assess liver issues. This is important because it highlights that even without typical warning signs, doctors should still consider bile-related problems in sickle cell patients, especially if they have had their gallbladder removed.
Who this helps: This helps doctors and healthcare providers in diagnosing biliary issues in children with sickle cell disease.
Robust interface and reduced operation pressure enabled by co-rolling dry-process for stable all-solid-state batteries.
2025
Nature communications
Lee DJ, Jeon Y, Lee JP, Zhang L, Koh KH +10 more
Plain English This study focused on improving the production of all-solid-state batteries, which are a cleaner alternative because they don’t use solvents. The researchers developed a method that creates a thin and strong layer of solid electrolyte and a high-performance positive electrode, achieving a stable battery that retains over 80% of its energy after 500 charging cycles while using lower pressure during production. This innovation could lead to safer and more efficient batteries for various applications, especially in electric vehicles and portable electronics.
Who this helps: This helps battery manufacturers and consumers looking for longer-lasting and safer battery technology.
Rubus coreanus extract prevents kidney fibrosis through TGF-β/Smad pathway inhibition.
2025
PloS one
Jin W, Cho A, Cho B, Shin N, Oh YK +3 more
Plain English This study looked at how an extract from the Rubus coreanus plant can prevent kidney damage caused by a condition that blocks urine flow. In tests with mice, the extract reduced kidney fibrosis from about 17% of the kidney area to 10%, showing a significant decrease in damage. The study also found that the extract helped kidney cells resist harmful changes caused by certain proteins.
Who this helps: This benefits patients at risk for kidney fibrosis, particularly those with urinary blockages.
PPARα Genetic Deletion Reveals Global Transcriptional Changes in the Brain and Exacerbates Cerebral Infarction in a Mouse Model of Stroke.
2025
International journal of molecular sciences
Hamblin MH, Boese AC, Murad R, Lee JP
Plain English This study looked at how a specific gene called PPARα affects the brain's response to ischemic stroke in mice. The researchers found that when PPARα was removed, it led to larger brain damage (infarct size) after a stroke, indicating that this gene plays a protective role. The changes in gene activity associated with the loss of PPARα might influence inflammation and cell death in the brain, highlighting it as a potential target for new stroke treatments.
Who this helps: This helps patients who suffer from strokes by pointing to new treatment options.
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial.
2025
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Jang Y, Park SD, Lee JP, Choi SH, Kong MG +7 more
Plain English This study looked at the effects of taking a one-month dual antiplatelet therapy (DAPT) with prasugrel and aspirin, followed by a lower dose of prasugrel alone in patients with a heart condition known as acute coronary syndrome who had received drug-coated stents. The results showed that only 4.9% of patients in the shorter treatment group experienced serious complications after a year, compared to 8.8% in the longer treatment group, which means a significant 49% reduction in negative outcomes. Additionally, bleeding events were much less common in the one-month treatment group, with only 1.2% experiencing any bleeding compared to 5.2% in the longer treatment group.
Who this helps: This benefits patients with acute coronary syndrome, reducing their risk of complications and bleeding while receiving treatment.
Weekend catch-up sleep and its association with chronic kidney disease and albuminuria in middle age and older adults from the National Health and Nutrition Examination Survey (2017-2020).
2025
Kidney research and clinical practice
Han SH, Ko A, Lee J, Kim DK, Kim YS +3 more
Plain English This study looked at how catching up on sleep over the weekend affects the risk of chronic kidney disease (CKD) in middle-aged and older adults. Researchers found that those who slept more than one hour extra on weekends had a 33% lower chance of having CKD and a 31% lower chance of having albuminuria (a sign of kidney damage) compared to those who didn't catch up on sleep. Specifically, getting 1 to 2 extra hours of sleep on weekends was especially helpful for people who sleep less than 6 hours on weekdays.
Who this helps: This benefits middle-aged and older adults who may struggle with sleep during the week.
Effect of off-label vitamin D analog use for albuminuria in early nondiabetic nephropathy: a double-blind, randomized, placebo-controlled trial.
2025
Kidney research and clinical practice
Han N, Kim DK, Lee H, Joo KW, Kim S +3 more
Plain English This study looked at the effects of a vitamin D treatment called calcitriol on reducing protein in the urine (albuminuria) in patients with early kidney disease who do not have diabetes. In the group taking calcitriol, the amount of protein in their urine decreased over time, with a change of 0.24 grams per gram at 24 weeks and 0.22 grams per gram at 48 weeks. However, while the treatment showed some promise, it wasn't enough to be seen as significantly better than the placebo after 24 and 48 weeks, and there were also no major safety concerns.
Who this helps: This research is relevant for patients with early nondiabetic kidney disease and the doctors treating them.
Deep learning-based quantitative analysis of glomerular morphology in IgA nephropathy whole slide images and its prognostic implications.
2025
Scientific reports
Cho SY, Kim Y, Park S, Paik JH, Chin HJ +14 more
Plain English This study examined how artificial intelligence can analyze features of kidney cells in patients with IgA nephropathy (IgAN) to improve predictions about disease progression. Researchers used a deep learning model to analyze 1,241 images of kidney samples and found that this AI method had a comparable ability to predict outcomes as traditional clinical methods, achieving accuracy scores of around 0.795 for internal validation. This is important because it shows that AI can provide valuable insights, potentially helping doctors better assess the risk of kidney disease progression.
Who this helps: This benefits patients with IgA nephropathy and their doctors.
Dioscin from smilax china rhizomes inhibits platelet activation and thrombus formation via up-regulating cyclic nucleotides.
2025
Scientific reports
Lee GH, Lee JP, Heo NY, Lee CD, Kim G +4 more
Plain English This study looked at how a substance called dioscin, found in the Smilax china plant, affects platelet activation, which is important because too many platelets can cause blood clots and heart disease. Researchers found that dioscin boosts the levels of certain molecules (cAMP and cGMP) that help prevent platelets from clumping together, reducing the formation of blood clots in experiments. Specifically, dioscin lowered thrombus formation significantly in lab tests, highlighting its potential as a treatment to help manage or prevent conditions related to blood clots.
Who this helps: This research benefits patients at risk for cardiovascular diseases caused by blood clotting.
Long-term impact of PMexposure on diabetic kidney disease patients considering time-dependent medication adjustment.
2025
Clinical kidney journal
Kwon S, Sim H, Ko A, Lee W, Kim H +7 more
Plain English This study looked at how air pollution affects patients with diabetic kidney disease (DKD) while considering their medications. Researchers followed nearly 9,500 patients for an average of 9 to 11 years and found that 20.6% of them progressed to end-stage kidney disease (ESKD) and 46.7% faced more serious health issues. Higher exposure to fine particulate matter (PM) was linked to a greater risk of ESKD progression, with a significant increase in risk noted (28% more likely), which highlights the ongoing impact of air quality on people with kidney disease.
Who this helps: This research benefits patients with diabetic kidney disease by emphasizing the importance of air quality in their health management.
Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice.
2025
The Journal of clinical investigation
Saka S, Lu Z, Wang Y, Liu P, Singh DK +9 more
Plain English This study focused on how a protein called YY1 affects the movement and survival of fetal blood stem cells in mice. Researchers discovered that without YY1, these stem cells could not properly migrate to their adult location in the bone marrow, leading to a significant loss of stem cells and ultimately causing death shortly after birth. Understanding these processes is crucial because it sheds light on how blood stem cells transition from their early development to adulthood, which could influence future treatments for blood-related diseases.
Who this helps: This research benefits scientists studying blood development and potential therapies for blood disorders.
Multimodal Imaging and Clinical Implications of Collagenous Fibroma in the Juxtaforaminal Premaxillary Fat Pad Mimicking Locoregional Tumor Recurrence: A Case Report and Literature Review.
2025
Current medical imaging
Lee JP, Baek HJ, Park KJ, Kim JP, An HJ +1 more
Plain English This study looked at a rare benign tumor called collagenous fibroma (CF) found in the fat pad near the upper jaw. A 48-year-old woman with a previous cancer history displayed symptoms that made doctors suspect her cancer had returned, but tests ultimately showed it was actually CF. This matters because it highlights how crucial it is for doctors to carefully consider a patient's history and test results to avoid misdiagnosis and ensure the right treatment.
Who this helps: This helps patients who may face similar diagnostic challenges after previous cancers.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Han SH, You E, Ko A, Kwon S, Lee D +10 more
Plain English This study looked at how long-term exposure to ozone affects kidney transplant patients. It involved 4,796 adults who had received transplants and found that higher ozone levels increased the risk of losing the kidney graft (by 60%) and dying (by 65%). Understanding these risks is crucial because it highlights the serious impact of air pollution on the health of kidney transplant recipients.
Who this helps: This information helps patients, doctors, and policymakers in managing health risks associated with air pollution.
Influence of urinary creatinine concentration and specific gravity correction in exposure assessment: Comparison between chronic kidney disease patients and general population.
2025
Environmental research
Lee I, Kim Y, Lee JP, Kim Y, Lee G +6 more
Plain English This study looked at how kidney health affects the way we measure certain chemicals in urine, specifically comparing chronic kidney disease (CKD) patients to the general population. The researchers found that in CKD patients, urine adjustments using creatinine or specific gravity led to higher levels of toxins, especially in those with worse kidney function, while the general population showed the opposite trend. This matters because it highlights the need to consider kidney function when assessing chemical exposure, ensuring assessments are accurate and relevant to health risks.
Who this helps: This helps patients with chronic kidney disease and healthcare providers monitoring their health.
Comparative Impact of Early Graft Function on Kidney Transplantation Outcomes According to Donor Types.
2025
Kidney360
Song J, Kang E, Jeong S, Son HE, Han A +9 more
Plain English This study examined how early kidney function after transplantation affects outcomes based on donor type—living or deceased. Among over 3,200 kidney transplant recipients, 11.2% had impaired early graft function, which increased the risk of complications: for those receiving kidneys from living donors, the likelihood of acute rejection went up by more than double, while those getting kidneys from deceased donors faced increased risks of graft failure and death. Understanding these differences is crucial for improving kidney transplant care and outcomes.
Who this helps: This benefits kidney transplant patients and their doctors.
Ambient AI-assited clinical documentation in surgical outpatient care: a preliminary study of usability, workflow, and patient experience.
2025
World journal of pediatric surgery
Harvey CJ, Wong V, Huynh W, Lee JP, Woo RK
Plain English This study looked at how using an AI assistant for clinical documentation affects the work of surgeons in outpatient care. The research found that 58% to 90% of surgical visits used the AI scribe, which reduced mental workload and feelings of being rushed—mental demand scores dropped from 14 to 5, and burnout rates decreased from 67% to 33%. Importantly, two surgeons said they could see more patients in a clinic. This is significant because it shows that AI can help ease paperwork, reduce stress for doctors, and potentially allow them to see more patients.
Who this helps: Patients and doctors.
Lithium diffusion-controlled Li-Al alloy negative electrode for all-solid-state battery.
2025
Nature communications
Jeon Y, Lee DJ, Zheng H, Behara SS, Lee JP +11 more
Plain English This study explored a new type of battery electrode made from a lithium-aluminum alloy, which can help improve the performance of all-solid-state batteries. Researchers found that electrodes with more lithium allowed for much faster movement of lithium ions, resulting in better battery efficiency with a high rate capability of 7 mA cm, and they maintained 83% of their original capacity after 2000 charge cycles. This matters because it could lead to longer-lasting and more powerful batteries for various devices and electric vehicles.
Who this helps: This helps battery manufacturers and consumers looking for more efficient energy storage solutions.
Differential impact of per- and polyfluoroalkyl substances exposure on hypertension risk by kidney function and metabolic status.
2025
Environment international
Kim Y, Lee I, Lee J, Lee G, Paek JH +5 more
Plain English This study looked at how certain environmental chemicals, called PFAS, affect the risk of high blood pressure (hypertension) based on kidney function and overall metabolic health. Among nearly 3,000 adults, higher levels of PFAS were found to be linked to higher hypertension risk, especially in those with better kidney function and metabolic conditions—specifically, those without obesity or high triglycerides. These findings underscore the need for people, especially those with good metabolic health, to reduce exposure to PFAS to potentially lower their hypertension risk.
Who this helps: This benefits patients, especially those concerned about high blood pressure and metabolic health.
Gut microbiome and metabolite signatures for predicting acute kidney transplant rejection: a prospective study.
2025
Scientific reports
Cho H, Nam H, Kim HE, Kim JE, Park JI +9 more
Plain English This study looked at how changes in gut bacteria and their byproducts might help predict acute kidney transplant rejection in patients. Researchers studied 97 kidney transplant patients and found that 33 of them experienced rejection. These patients had fewer types of bacteria in their guts and different levels of specific compounds compared to those who did not reject their transplant, indicating that monitoring gut health could improve treatment outcomes.
Who this helps: Patients undergoing kidney transplants.
Synergistic effect of periodontitis and C-reactive protein levels on mortality: NHANES 2001-2004.
2024
PloS one
Han M, Lee W, Ahn S, Kang MH, Hwang HS +7 more
Plain English This study looked at how periodontitis (a serious gum disease) and high levels of C-reactive protein (CRP, a marker of inflammation) affect the risk of dying. Researchers found that adults with both periodontitis and CRP levels above 0.5 mg/dL had a much higher mortality risk, with a relative risk of 2.01, compared to those without gum disease and lower CRP levels. This highlights the need for better management of gum health and inflammation in order to reduce the risk of death, especially for people over 60.
Who this helps: This benefits patients with periodontitis and their healthcare providers.
Effects of dietary fatty acid on all-cause mortality according to the kidney function based on the nationwide population study.
2024
Kidney research and clinical practice
Kim Y, Ha K, Lee J, Bae E, Paek JH +6 more
Plain English This study looked at how different types of dietary fats affect the risk of death, particularly in people with varying levels of kidney function. It found that among over 44,000 people followed for about 10.5 years, those with slightly reduced kidney function (eGFR between 60-90) had a 20% higher risk of death when they consumed more saturated fats. In contrast, certain healthy fats, like omega-3s, lowered the risk of death in the same group. Understanding these effects is crucial for tailoring dietary recommendations, especially for individuals with mild kidney issues.
Who this helps: This helps patients with kidney function that is slightly reduced.
Predicting early mortality in hemodialysis patients: a deep learning approach using a nationwide prospective cohort in South Korea.
2024
Scientific reports
Noh J, Park SY, Bae W, Kim K, Cho JH +7 more
Plain English This study looked at over 3,200 patients starting hemodialysis in South Korea to find out what factors affect their risk of dying early. Researchers found that the overall death rate was 19.3% during an average follow-up of about 5.5 years. They identified that patients with shorter dialysis durations and higher health scores faced much greater risks—up to 7.76 times higher—of dying early, highlighting the importance of managing other health conditions and dialysis effectiveness for better patient outcomes.
Who this helps: This benefits patients on hemodialysis and their healthcare providers by identifying key risk factors to improve care and outcomes.
Fostering international coordination in renal disaster preparedness: a collaboration between the Renal Disaster Preparedness Working Group of the International Society of Nephrology and the Disaster Preparedness and Response Committee of the Korean Society of Nephrology.
Acute kidney injury after non-cardiac major surgery: has it reduced?
2024
Clinical kidney journal
Cho JM, Kwon S, Yang S, Park J, Jeong S +12 more
Plain English This study looked at the rate of acute kidney injury (AKI) that occurs after major surgeries not related to the heart, examining over 138,000 patients from 2005 to 2020. The researchers found that the overall incidence of post-operative acute kidney injury (PO-AKI) dropped from 8.6% to 5.1%, but the rate of severe cases remained stable at around 0.8%. This matters because it indicates that while early detection and prevention efforts may be working to reduce mild cases of kidney injury after surgery, the more serious cases have not improved, highlighting a need for better interventions.
Who this helps: This helps patients undergoing major surgery and their doctors.